NEW YORK, May 14 - AlphaGene is up for sale, an executive at the company told GenomeWeb today.

"We are in the process of selling the company," said Donald McCarren, president and CEO of the privately held functional genomics firm. "We don't have the resources to fully develop the value inside the company."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.